WuXi 2269-0.77 % decrease; red down pointing triangle Biologics agreed to sell an overseas vaccine facility to Merck MRK 2.88 % increase; green up pointing triangle & Co. for half a billion ...

CORRECTION: WuXi Biologics has disputed a claim by WBJ construction has stopped at its Worcester facility.An earlier version of this article incorrectly conflated details involving WuXi Biologics ...

Oct 3 (Reuters) - WuXi AppTec (603259.SS), opens new tab and WuXi Biologics (2269.HK), opens new tab are planning to sell some of their operations after the Chinese biotech companies were targeted ...

Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its ...

WuXi AppTec offered its annual prediction as it reported 2.5% revenue growth in 2023 to 40.34 billion yuan ($5.6 billion). Taking marketed COVID-19 projects out of the mix, WuXi’s growth was ...

A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology companies including WuXi AppTec and BGI would give U.S. companies until 2032 to end work ...

WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and life sciences ...

WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY PR Newswire Mon, Apr ...

The U.S. House of Representatives took another step to curb Chinese companies’ U.S. operations by passing a draft of the Biosecure Act, prompting China-based biotech company WuXi AppTec and its ...

In June, for instance, WuXi Biologics unveiled plans to expand its operations in Germany. As part of the expansion, the company’s filling and freeze-drying facility in Leverkusen, Germany ...